门冬胰岛素和生物合成人胰岛素治疗妊娠期糖尿病疗效及妊娠结局的分析.pdfVIP

it埠医营llf 2016 年8 月第23 卷第8 期 .1089. ·论著· ( I降床研究) 门冬膜岛素和生物合成人膜岛素治疗姬振期糖尿病 疗效及姬振结局的分析 龙隽，许可可，刘海英 (广东省深圳市罗湖区人民医院妇产科，广东深圳 5181∞) [摘要] 目的比较门冬膜岛素和生物合成人且夷岛素治疗娃娘期糖尿病 (GDM) 的疗效及对任娘结局的影响。方法选择需 股岛素治疗的 GDM 孕妇 63 例，研究纽32 例采用门冬且是岛素治疗，对照纽 31 例采用诺和灵治疗。结果研究组孕32 周时的空 腹血糖、餐后 2h 血糖显著低于对照纽 (PO.05 ， PO.01) ， 两组分娩前的空腹血糖及餐后 2h 血糖比较无统计学差异 (PO.05) 。 两组的任娘结局比较差异无统计学意义 (PO.O日，研究纽用药期间低血糖发生率显著低于对照纽 (PO.05)。结论门冬族岛素 和生物合成人股岛素用于任生在期糖尿病治疗的疗效相当，任娘结局相似，但门冬肢岛素临床副反应小，调整血糖达标时间更快。 [关键词] 娃生在期糖尿病;门冬族岛素;生物合成人股岛素 中图分类号: R714.256 文献标识码: A doi: 1O.3969/j .issn.1674-4659.20 16.08.1089 Effects and Pregnancy Outcomes of NovorRapid and Novolin R in the Treatment of Gestational Diabetes Mellitus LONG }u棚， XU Keke , L/U Haiying (Depαrt阳nt of Obstetrics and Gynecology, the People s Hospit a1 of Luohu District, Shenzhen 5181ω1， China) [Abstract] Objective To compare the effects and pregnancy outcomes of NovoRapid and Novolin R in the treatment of gestational diabetes mellitus (GDM). Methods In 63 cases ofGDM pregnancy women , 32 cases ofstudy group were treated with NovoRapid , and 31 cases of control group were treated with Novolin R. Results The levels of fasting blood glucose and 2-hour postprandial blood glucose at 32 weeks ofpregnancy in study group were significantly lower than those in control group (P0.05, PO.OI) , while no statistical di能rence was found between two groups before delivery (P0.05). The pregnancy outcomes had no statistical difference between two groups (P0.05); The incidence of hypoglycemia during drug use in the study grou